...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: a bit more volume and a bit higher

ZHCLF continues to inch up.  Volume has been increasing since late last year.  Recently the bid/ask is a bit tighter.

No idea if this will continue but I think awareness is spreading and a few more shares are entering this "unofficial" float.

 

Share
New Message
Please login to post a reply